The store will not work correctly when cookies are disabled.
N-(5-Bromopyridin-2-yl)-4-phenoxybutanamide
ID: ALA4546726
PubChem CID: 84376194
Max Phase: Preclinical
Molecular Formula: C15H15BrN2O2
Molecular Weight: 335.20
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCCOc1ccccc1)Nc1ccc(Br)cn1
Standard InChI: InChI=1S/C15H15BrN2O2/c16-12-8-9-14(17-11-12)18-15(19)7-4-10-20-13-5-2-1-3-6-13/h1-3,5-6,8-9,11H,4,7,10H2,(H,17,18,19)
Standard InChI Key: VSMNGDLLMZDBMO-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
31.8897 -4.3005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8885 -5.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5966 -5.5290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3062 -5.1196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3034 -4.2969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5948 -3.8917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1819 -3.8921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4743 -4.3009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7665 -3.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0588 -4.3012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3510 -3.8928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6434 -4.3016 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3508 -3.0756 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.9356 -3.8931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9395 -3.0760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2325 -2.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5239 -3.0765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5268 -3.8979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2343 -4.3026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8156 -2.6690 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 335.20 | Molecular Weight (Monoisotopic): 334.0317 | AlogP: 3.64 | #Rotatable Bonds: 6 |
Polar Surface Area: 51.22 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.09 | CX Basic pKa: 2.29 | CX LogP: 3.40 | CX LogD: 3.40 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.82 | Np Likeness Score: -1.66 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |